<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Immun Ageing</journal-id><journal-id journal-id-type="iso-abbrev">Immun Ageing</journal-id><journal-title-group><journal-title>Immunity &amp; Ageing : I &amp; A</journal-title></journal-title-group><issn pub-type="epub">1742-4933</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3402998</article-id><article-id pub-id-type="publisher-id">1742-4933-9-8</article-id><article-id pub-id-type="pmid">22524430</article-id><article-id pub-id-type="doi">10.1186/1742-4933-9-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Genetics of longevity. data from the studies on Sicilian centenarians </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Balistreri</surname><given-names>Carmela R</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>carmelarita.balistreri@unipa.it</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Candore</surname><given-names>Giuseppina</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>giuseppina.candore@unipa.it</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Accardi</surname><given-names>Giulia</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>giulia.accardi@unipa.it</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Bova</surname><given-names>Manuela</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>manuelabova@hotmail.it</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Buffa</surname><given-names>Silvio</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>silvio.buffa@unipa.it</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Bulati</surname><given-names>Matteo</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>matteo.bulati@unipa.it</email></contrib><contrib contrib-type="author" id="A7"><name><surname>Forte</surname><given-names>Giusi I</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>gforte77@libero.it</email></contrib><contrib contrib-type="author" id="A8"><name><surname>Listì</surname><given-names>Florinda</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>florinda.listi@libero.it</email></contrib><contrib contrib-type="author" id="A9"><name><surname>Martorana</surname><given-names>Adriana</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>adriana.martorana@unipa.it</email></contrib><contrib contrib-type="author" id="A10"><name><surname>Palmeri</surname><given-names>Marisa</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>marisapalmeri@alice.it</email></contrib><contrib contrib-type="author" id="A11"><name><surname>Pellicanò</surname><given-names>MariaValeria</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>valinap@hotmail.com</email></contrib><contrib contrib-type="author" id="A12"><name><surname>Vaccarino</surname><given-names>Loredana</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>loredanavaccarino@libero.it</email></contrib><contrib contrib-type="author" id="A13"><name><surname>Scola</surname><given-names>Letizia</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>letiizia.scola@unipa.it</email></contrib><contrib contrib-type="author" id="A14"><name><surname>Lio</surname><given-names>Domenico</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>domenico.lio@unipa.it</email></contrib><contrib contrib-type="author" id="A15"><name><surname>Colonna-Romano</surname><given-names>Giuseppina</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>giuseppina.colonnaromano@unipa.it</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Pathobiology and Medical and Forensic Biotechnologies, University of Palermo, Corso Tukory 211, Palermo 90134, Italy</aff><aff id="I2"><label>2</label>Department of Internal Medicine II, Center for Medical Research, University of Tübingen, Tübingen Ageing and Tumor Immunology group, Waldhörnlestr. 22, Tübingen 72072, Germany</aff><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>23</day><month>4</month><year>2012</year></pub-date><volume>9</volume><fpage>8</fpage><lpage>8</lpage><history><date date-type="received"><day>29</day><month>3</month><year>2012</year></date><date date-type="accepted"><day>23</day><month>4</month><year>2012</year></date></history><permissions><copyright-statement>Copyright ©2012 Balistreri et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>Balistreri et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.immunityageing.com/content/9/1/8"/><abstract><p><SecTag type="ABS"><text><SENT sid="1" pm="."><plain>The demographic and social changes of the past decades have determined improvements in public health and longevity. </plain></SENT>
<SENT sid="2" pm="."><plain>So, the number of centenarians is increasing as a worldwide phenomenon. </plain></SENT>
<SENT sid="3" pm="."><plain>Scientists have focused their attention on centenarians as optimal model to address the biological mechanisms of "successful and unsuccessful ageing". </plain></SENT>
<SENT sid="4" pm="."><plain>They are equipped to reach the extreme limits of human life span and, most importantly, to show relatively good health, being able to perform their routine daily life and to escape fatal age-related diseases, such as cardiovascular diseases and cancer. </plain></SENT>
<SENT sid="5" pm="."><plain>Thus, particular attention has been centered on their genetic background and immune system. </plain></SENT>
<SENT sid="6" pm="."><plain>In this review, we report our data gathered for over 10 years in Sicilian centenarians. </plain></SENT>
<SENT sid="7" pm="."><plain>Based on results obtained, we suggest longevity as the result of an optimal performance of immune system and an over-expression of anti-inflammatory sequence variants of immune/inflammatory genes. </plain></SENT>
<SENT sid="8" pm="."><plain>However, as well known, genetic, epigenetic, stochastic and environmental factors seem to have a crucial role in ageing and longevity. </plain></SENT>
<SENT sid="9" pm="."><plain>Epigenetics is associated with ageing, as demonstrated in many studies. </plain></SENT>
<SENT sid="10" pm="."><plain>In particular, ageing is associated with a global loss of methylation state. </plain></SENT>
<SENT sid="11" pm="."><plain>Thus, the aim of future studies will be to analyze the weight of epigenetic changes in ageing and longevity. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>Immune system</kwd><kwd>Genetics</kwd><kwd>Pro/anti-inflammatory polymorphisms</kwd><kwd>Epigenomics</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec><title><text><SENT sid="12" pm="."><plain>Introduction </plain></SENT>
</text></title><sec><title><text><SENT sid="13" pm="."><plain>Data from centenarian offspring </plain></SENT>
</text></title><p><text><SENT sid="14" pm="."><plain>As well known, life expectancy is a familial trait and longevity is determined by different factors. </plain></SENT>
<SENT sid="15" pm="."><plain>In particular, the environmental milieu and genetic background play a central role. </plain></SENT>
<SENT sid="16" pm="."><plain>As demonstrated by many epidemiological studies, family members of long-lived subjects have a significant survival advantage compared to general population. </plain></SENT>
<SENT sid="17" pm="."><plain>In this context, the study of centenarian offspring (CO), a group of healthy elderly people with a familiar history of longevity, might help gerontologists to better identify the correlation between genetic profile and hope of a healthy ageing. </plain></SENT>
<SENT sid="18" pm="."><plain>Previous studies have reported that CO, like their centenarian parents, have genetic and immune system advantages, which reflect a minor risk to develop major age-related diseases, such as cardiovascular diseases, hypertension or diabetes mellitus as well as cancer [1,2]. </plain></SENT>
<SENT sid="19" pm="."><plain>The lower cardiovascular disease risk in CO suggests the probability that CO have some protective factors against atherosclerosis, such as a good lipid profile. </plain></SENT>
<SENT sid="20" pm="."><plain>Male CO have higher plasma HDL-C levels and lower plasma LDL-C levels. </plain></SENT>
<SENT sid="21" pm="."><plain>Since lipid profile is directly correlated to atherosclerotic cardiovascular diseases, this metabolic feature could preserve CO both to develop these diseases and, as consequence, to reach a healthy ageing and longer survival [3]. </plain></SENT>
<SENT sid="22" pm="."><plain>Furthermore, Rose et al. [4] reported that centenarians and CO show significantly higher levels of heteroplasmy in mtDNA control region than controls, a favorable condition for longevity. </plain></SENT>
</text></p><p><text><SENT sid="23" pm="."><plain>In these last years, some researchers have speculated about the distinctive immunological profile of offspring enriched for longevity respect to the immunological features of coeval elderly. </plain></SENT>
<SENT sid="24" pm="."><plain>The cytomegalovirus (CMV) is one of the most common viruses that affect elderly people. </plain></SENT>
<SENT sid="25" pm="."><plain>Many evidences have shown that CMV infection may influence the T cell subset distribution, having an essential role in immunosenescence [5-7]. </plain></SENT>
<SENT sid="26" pm="."><plain>CMV infection is strongly related to both a reduction of CD8+CD45+CCR7+CD27+CD28+ naïve T cells and to a contemporarily increase of CD8+CD45RA-CCR7-CD27-CD28- late differentiated effector memory and CD45RA-re-expressing T cells. </plain></SENT>
<SENT sid="27" pm="."><plain>These parameters are considered typical of immunosenescence in elderly. </plain></SENT>
<SENT sid="28" pm="."><plain>Recently, it has been demonstrated that CMV-seropositive offspring of long-lived people don't show the age-associated decrease of naïve T cells. </plain></SENT>
<SENT sid="29" pm="."><plain>On the other hand, memory T cell subsets above described do not increase in offspring of long-lived families, differently from that observed in age-matched controls [8]. </plain></SENT>
<SENT sid="30" pm="."><plain>It has been also demonstrated that CMV-seropositive offspring of long-lived people have reduced levels of CD8+ T cells expressing CD57 and KLRG1, sometimes referred as "marker of senescence", when compared to their CMV-infected age-matched controls. </plain></SENT>
<SENT sid="31" pm="."><plain>The reduction of effector memory T cells lacking the expression of CD27 and CD28 and expressing CD57 and KLRG1, observed in CMV-infected offspring could explain their high proliferative response against CMV. </plain></SENT>
<SENT sid="32" pm="."><plain>The CMV-seropositive offspring have also shown significantly lower CRP levels compared to their CMV-seropositive age-matched controls that could be related to a lower pro-inflammatory status [8]. </plain></SENT>
</text></p><p><text><SENT sid="33" pm="."><plain>During ageing, B cell compartment also shows significant modifications in numbers and functions [9-12]. </plain></SENT>
<SENT sid="34" pm="."><plain>In fact, advanced age is per se a condition characterized by lack of B clonotypic immune response to new extracellular pathogens. </plain></SENT>
<SENT sid="35" pm="."><plain>In any event, data are suggesting that the loss of naive B cells could represent a hallmark of immunosenescence [13]. </plain></SENT>
<SENT sid="36" pm="."><plain>On the other hand, a B cell population lacking of both IgD and CD27 resulted increased in healthy elderly [14]. </plain></SENT>
<SENT sid="37" pm="."><plain>We have suggested that this IgD-CD27- B cell subset is a population of memory B cells lacking CD27, a typical memory marker, likely considered a late memory exhausted B cell subset (Table 1) [14-16]. </plain></SENT>
<SENT sid="38" pm="."><plain>This population resulted also increased in active Lupus patients [17], in healthy subjects challenged with respiratory syncitial virus [18], and in HIV patients [19]. </plain></SENT>
<SENT sid="39" pm="."><plain>CO don't show the typical naïve/memory B cell shift observed in elderly. </plain></SENT>
<SENT sid="40" pm="."><plain>Although a decreased B cell count was observed in CO and their age-matched controls, it has been demonstrated that naïve B cells (IgD+CD27-) were more abundant and DN B cells (IgD-CD27-) were significantly decreased, as looked similarly in young people [20]. </plain></SENT>
<SENT sid="41" pm="."><plain>This B cells distribution in CO could suggest that antigenic load or inflammatory environment play a central role in exhaustion of the B cell branch. </plain></SENT>
<SENT sid="42" pm="."><plain>It is well documented that the quality and the size of the humoral immune response declines with age [15,21-26]. </plain></SENT>
<SENT sid="43" pm="."><plain>This change is characterized by lower antibody responses and decreased production of high affinity antibodies. </plain></SENT>
<SENT sid="44" pm="."><plain>The evaluation of IgM secreted in CO serum shows that the values are within the range of the levels observed in young subjects [20]. </plain></SENT>
<SENT sid="45" pm="."><plain>In this way, CO could have a bigger advantage to fight against new infections and appropriately respond to vaccinations, giving them a selective advantage for longevity in healthiness. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><text><SENT sid="46" pm="."><plain>Main modifications of B cells and B cells products in elderly human observed in our laboratory </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><text><SENT sid="47" pm="."><plain>B cells or B cells products </plain></SENT>
</text></th><th align="left"><text><SENT sid="48" pm="."><plain>Changes </plain></SENT>
</text></th><th align="left"><text><SENT sid="49" pm="."><plain>References </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left"><text><SENT sid="50" pm="."><plain>Total B cells (percentage) </plain></SENT>
</text></td><td align="left"><text><SENT sid="51" pm="."><plain>↓ </plain></SENT>
</text></td><td align="left"><text><SENT sid="52" pm="."><plain>[9] </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="53" pm="."><plain>CD19+CD5+ B1 cells (percentage and absolute number) </plain></SENT>
</text></td><td align="left"><text><SENT sid="54" pm="."><plain>↓ </plain></SENT>
</text></td><td align="left"><text><SENT sid="55" pm="."><plain>[10] </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="56" pm="."><plain>IgG, IgA </plain></SENT>
</text></td><td align="left"><text><SENT sid="57" pm="."><plain>↑ </plain></SENT>
</text></td><td align="left"><text><SENT sid="58" pm="."><plain>[11] </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="59" pm="."><plain>IgM, IgD </plain></SENT>
</text></td><td align="left"><text><SENT sid="60" pm="."><plain>↓ </plain></SENT>
</text></td><td align="left"><text><SENT sid="61" pm="."><plain>[11] </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="62" pm="."><plain>IgE </plain></SENT>
</text></td><td align="left"><text><SENT sid="63" pm="."><plain>= </plain></SENT>
</text></td><td align="left"><text><SENT sid="64" pm="."><plain>[11] </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="65" pm="."><plain>Autoantibodies </plain></SENT>
</text></td><td align="left"><text><SENT sid="66" pm="."><plain>↑ </plain></SENT>
</text></td><td align="left"><text><SENT sid="67" pm="."><plain>[12] </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="68" pm="."><plain>Naive (IgD+CD27-) </plain></SENT>
</text></td><td align="left"><text><SENT sid="69" pm="."><plain>↓ </plain></SENT>
</text></td><td align="left"><text><SENT sid="70" pm="."><plain>[13] </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="71" pm="."><plain>DN (IgD-CD27-) </plain></SENT>
</text></td><td align="left"><text><SENT sid="72" pm="."><plain>↑ </plain></SENT>
</text></td><td align="left"><text><SENT sid="73" pm="."><plain>[14-16] </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><p><text><SENT sid="74" pm="."><plain>In conclusion, individuals genetically enriched for longevity possess immune different signatures respect to those of the general population (Table 2). </plain></SENT>
<SENT sid="75" pm="."><plain>This suggests the idea of the "familiar youth" of the immune system. </plain></SENT>
<SENT sid="76" pm="."><plain>In addition, the lower pro-inflammatory status in CMV-infected offspring of long-lived people might represent an optimal advantage for healthy longevity and against mortality associated to major age-related diseases. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T2" position="float"><label>Table 2</label><caption><p><text><SENT sid="77" pm="."><plain>Cellular and humoral immune modification in offspring from longevity families compared to their AM controls </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><text><SENT sid="78" pm="."><plain>T and B cell Phenotypes and Products </plain></SENT>
</text></th><th align="left"><text><SENT sid="79" pm="."><plain>Changes </plain></SENT>
</text></th><th align="left"><text><SENT sid="80" pm="."><plain>References </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left"><text><SENT sid="81" pm="."><plain>Naïve T cells (CD3+CD8+CD45RA+CCR7+CD27+CD28+) </plain></SENT>
</text></td><td align="left"><text><SENT sid="82" pm="."><plain>Increase </plain></SENT>
</text></td><td align="left"><text><SENT sid="83" pm="."><plain>[8] </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="84" pm="."><plain>Late differentiated effector memory T cells (CD3+CD8+CD45RA-CCR7-CD27-CD28-) </plain></SENT>
</text></td><td align="left"><text><SENT sid="85" pm="."><plain>Decrease </plain></SENT>
</text></td><td align="left"><text><SENT sid="86" pm="."><plain>[8] </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="87" pm="."><plain>TEMRA (CD3+CD8+CD45RA+CCR7-CD27-CD28-) </plain></SENT>
</text></td><td align="left"><text><SENT sid="88" pm="."><plain>Decrease </plain></SENT>
</text></td><td align="left"><text><SENT sid="89" pm="."><plain>[8] </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="90" pm="."><plain>Naïve B cells (IgD+CD27-) </plain></SENT>
</text></td><td align="left"><text><SENT sid="91" pm="."><plain>Increase </plain></SENT>
</text></td><td align="left"><text><SENT sid="92" pm="."><plain>[20] </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="93" pm="."><plain>Double Negative B cells (IgG+/IgA+IgD-CD27-) </plain></SENT>
</text></td><td align="left"><text><SENT sid="94" pm="."><plain>Decrease </plain></SENT>
</text></td><td align="left"><text><SENT sid="95" pm="."><plain>[20] </plain></SENT>
</text></td></tr><tr><td align="left"><text><SENT sid="96" pm="."><plain>Serum IgM </plain></SENT>
</text></td><td align="left"><text><SENT sid="97" pm="."><plain>Increase </plain></SENT>
</text></td><td align="left"><text><SENT sid="98" pm="."><plain>[20] </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag></sec><sec><title><text><SENT sid="99" pm="."><plain>Gender and longevity </plain></SENT>
</text></title><p><text><SENT sid="100" pm="."><plain>A characteristic enigma of longevity is the gender and the social phenomenon of "feminization of old age". </plain></SENT>
<SENT sid="101" pm="."><plain>The demographic and social changes of the past decades, responsible for longevity and the improvements in public health, have created new and often very dissimilar realties for women and men. </plain></SENT>
<SENT sid="102" pm="."><plain>People are all aware that they differ in their anatomy and physiology, but also in more complex traits, such as lifespan (in Italy, 78.8 years for men and 84.1 years for women, respectively) and mortality [27-29]. </plain></SENT>
<SENT sid="103" pm="."><plain>No conclusive explanation for these new differences is actually demonstrated. </plain></SENT>
<SENT sid="104" pm="."><plain>An intricate interaction between environmental, social structural, behavioural (i.e. the complex pattern of roles and values that define what is thought as masculine and feminine) and genetic factors have been suggested as the more probable reason [30-32]. </plain></SENT>
</text></p><p><text><SENT sid="105" pm="."><plain>From a genetic prospective, our suggestion based on the studies in Sicilian population supports a female-specific gene-longevity association, by emphasizing the paradoxical role of socio-cultural habits in female longevity [33]. </plain></SENT>
<SENT sid="106" pm="."><plain>This concerns the HFE gene, the most telomeric HLA class I gene, codifying for a class I α chain, the HFE protein, which seemingly no longer participates in immunity. </plain></SENT>
<SENT sid="107" pm="."><plain>It has lost its ability to bind peptides due to a definitive closure of the antigen binding cleft that prevents peptide binding and presentation. </plain></SENT>
<SENT sid="108" pm="."><plain>The HFE protein, expressed on crypt enterocytes of the duodenum, regulates the iron uptake by intestinal cells, having acquired the ability to form complex with the receptor for iron-binding transferring. </plain></SENT>
<SENT sid="109" pm="."><plain>Mutations in HFE gene are associated with hereditary hemochromatosis, a disorder caused by excessive iron uptake [34,35]. </plain></SENT>
<SENT sid="110" pm="."><plain>Three common mutations, C282Y, H63D and S65C, have been identified in HFE gene. </plain></SENT>
<SENT sid="111" pm="."><plain>In particular, the C282Y mutation (a cysteine-to-tyrosine mutation at amino acid 282) destroys its ability to make up a heterodimer with β2-microglobulin. </plain></SENT>
<SENT sid="112" pm="."><plain>The defective HFE protein fails to associate to the transferring receptor, and the complex cannot be transported to the surface of the duodenal crypt cells. </plain></SENT>
<SENT sid="113" pm="."><plain>As a consequence, in homozygous people, two to three times the normal amount of iron is absorbed from food by the intestine, resulting in end-organ damage and reducing lifespan. </plain></SENT>
<SENT sid="114" pm="."><plain>Two other mutations, H63D (a histidine to aspartate at amino acid 63) and S65C (a serine to cysteine at amino acid 65), are associated with milder forms of this disease [34,35]. </plain></SENT>
</text></p><p><text><SENT sid="115" pm="."><plain>An association between C282Y mutation and longevity characterizes the Sicilian population studied [33]. </plain></SENT>
<SENT sid="116" pm="."><plain>In particular, women carriers of C282Y mutation had a higher frequency among the oldest old compared to control women (Table 3). </plain></SENT>
<SENT sid="117" pm="."><plain>Thus, the C282Y mutation may confer a selective advantage in terms of longevity in Sicilian women. </plain></SENT>
<SENT sid="118" pm="."><plain>Considering the historical and social context in which the generation of women under study lived, our data seem to propose that the possession of iron-sparing alleles significantly increases the possibility for women to reach longevity. </plain></SENT>
<SENT sid="119" pm="."><plain>For instance, in Sicily, many pregnancies and an iron-poor diet, consisting mainly in grains, vegetables, and fruits, were still the rule for women born at the beginning of last century. </plain></SENT>
<SENT sid="120" pm="."><plain>In fact, meat was available for men but not for women; this clearly explains how genetic background also interacts with culture habits [30,31,33]. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T3" position="float"><label>Table 3</label><caption><p><text><SENT sid="121" pm="."><plain>Data from our investigations in Sicilian population </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="6"><text><SENT sid="122" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="123" pm="."><plain>Gene </plain></SENT>
</text></td><td align="center"><text><SENT sid="124" pm="."><plain>Alleles of genetic variants </plain></SENT>
</text></td><td align="center"><text><SENT sid="125" pm="."><plain>Centenarians </plain></SENT>
</text></td><td align="center"><text><SENT sid="126" pm="."><plain>Young controls (&lt; 55 years) </plain></SENT>
</text></td><td/><td align="center"><text><SENT sid="127" pm="."><plain>P </plain></SENT>
</text></td></tr><tr><td colspan="6"><text><SENT sid="128" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td/><td/><td align="center"><text><SENT sid="129" pm="."><plain>N = 35 females </plain></SENT>
</text></td><td align="center"><text><SENT sid="130" pm="."><plain>N = 106 females </plain></SENT>
</text></td><td/><td/></tr><tr><td colspan="6"><text><SENT sid="131" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="132" pm="."><plain>HFE </plain></SENT>
</text></td><td align="center"><text><SENT sid="133" pm="."><plain>C282 </plain></SENT>
</text></td><td align="center"><text><SENT sid="134" pm="."><plain>47 (84%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="135" pm="."><plain>132 (0%) </plain></SENT>
</text></td><td/><td align="center"><text><SENT sid="136" pm="."><plain>8.3 × 10-5 [33] </plain></SENT>
</text></td></tr><tr><td/><td align="center"><text><SENT sid="137" pm="."><plain>282Y </plain></SENT>
</text></td><td align="center"><text><SENT sid="138" pm="."><plain>9 (16%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="139" pm="."><plain>0 (0%) </plain></SENT>
</text></td><td/><td/></tr><tr><td colspan="6"><text><SENT sid="140" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="141" pm="."><plain>Genes </plain></SENT>
</text></td><td align="center"><text><SENT sid="142" pm="."><plain>Alleles of SNPs or genetic variants </plain></SENT>
</text></td><td align="center"><text><SENT sid="143" pm="."><plain>Centenarians </plain></SENT>
</text></td><td align="center"><text><SENT sid="144" pm="."><plain>Young controls (&lt; 55 years) </plain></SENT>
</text></td><td align="center"><text><SENT sid="145" pm="."><plain>MI patients (&lt; 55 years) </plain></SENT>
</text></td><td align="center"><text><SENT sid="146" pm="."><plain>P </plain></SENT>
</text></td></tr><tr><td colspan="6"><text><SENT sid="147" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td/><td/><td align="center"><text><SENT sid="148" pm="."><plain>N = 55 males </plain></SENT>
</text></td><td align="center"><text><SENT sid="149" pm="."><plain>N = 127 males </plain></SENT>
</text></td><td align="center"><text><SENT sid="150" pm="."><plain>N = 105 males </plain></SENT>
</text></td><td/></tr><tr><td colspan="6"><text><SENT sid="151" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="152" pm="."><plain>TLR4 </plain></SENT>
</text></td><td align="center"><text><SENT sid="153" pm="."><plain>+896A </plain></SENT>
</text></td><td align="center"><text><SENT sid="154" pm="."><plain>94 (85.4%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="155" pm="."><plain>239 (94.1%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="156" pm="."><plain>205 (97.6%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="157" pm="."><plain>&lt; 0.001 [49] </plain></SENT>
</text></td></tr><tr><td align="center"/><td align="center"><text><SENT sid="158" pm="."><plain>+896 G </plain></SENT>
</text></td><td align="center"><text><SENT sid="159" pm="."><plain>16 (14.6%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="160" pm="."><plain>15 (5.9%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="161" pm="."><plain>5 (2.4%) </plain></SENT>
</text></td><td align="center"/></tr><tr><td colspan="6"><text><SENT sid="162" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td/><td/><td align="center"><text><SENT sid="163" pm="."><plain>N = 123 males </plain></SENT>
</text></td><td align="center"><text><SENT sid="164" pm="."><plain>N = 136 males </plain></SENT>
</text></td><td align="center"><text><SENT sid="165" pm="."><plain>N = 133 males </plain></SENT>
</text></td><td/></tr><tr><td colspan="6"><text><SENT sid="166" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="167" pm="."><plain>CCR5 </plain></SENT>
</text></td><td align="center"><text><SENT sid="168" pm="."><plain>WT </plain></SENT>
</text></td><td align="center"><text><SENT sid="169" pm="."><plain>221(89.8%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="170" pm="."><plain>252 (92.6%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="171" pm="."><plain>263 (98.8%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="172" pm="."><plain>0.00006 [48] </plain></SENT>
</text></td></tr><tr><td align="center"/><td align="center"><text><SENT sid="173" pm="."><plain>Δ32 </plain></SENT>
</text></td><td align="center"><text><SENT sid="174" pm="."><plain>25 (10.2%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="175" pm="."><plain>20 (7.4%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="176" pm="."><plain>3 (1.2%) </plain></SENT>
</text></td><td align="center"/></tr><tr><td colspan="6"><text><SENT sid="177" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td/><td/><td align="center"><text><SENT sid="178" pm="."><plain>N = 96 males </plain></SENT>
</text></td><td align="center"><text><SENT sid="179" pm="."><plain>N = 170 males </plain></SENT>
</text></td><td align="center"><text><SENT sid="180" pm="."><plain>N = 140 males </plain></SENT>
</text></td><td/></tr><tr><td colspan="6"><text><SENT sid="181" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="182" pm="."><plain>Cox-2 </plain></SENT>
</text></td><td align="center"><text><SENT sid="183" pm="."><plain>-765 G </plain></SENT>
</text></td><td align="center"><text><SENT sid="184" pm="."><plain>122 (63.5%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="185" pm="."><plain>240 (70.6%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="186" pm="."><plain>232(82.8%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="187" pm="."><plain>0.000007 [47] </plain></SENT>
</text></td></tr><tr><td align="center"/><td align="center"><text><SENT sid="188" pm="."><plain>-765 C </plain></SENT>
</text></td><td align="center"><text><SENT sid="189" pm="."><plain>70(36.5%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="190" pm="."><plain>100(29.4%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="191" pm="."><plain>48(17.2%) </plain></SENT>
</text></td><td align="center"/></tr><tr><td align="center"><text><SENT sid="192" pm="."><plain>5-Lo </plain></SENT>
</text></td><td align="center"><text><SENT sid="193" pm="."><plain>-1708 G </plain></SENT>
</text></td><td align="center"><text><SENT sid="194" pm="."><plain>180 (93.7%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="195" pm="."><plain>302(88.8%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="196" pm="."><plain>224(80%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="197" pm="."><plain>0.00003 [47] </plain></SENT>
</text></td></tr><tr><td align="center"/><td align="center"><text><SENT sid="198" pm="."><plain>-1708A </plain></SENT>
</text></td><td align="center"><text><SENT sid="199" pm="."><plain>12(6.3%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="200" pm="."><plain>38(11.2%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="201" pm="."><plain>56(20%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="202" pm="."><plain>0.001 </plain></SENT>
</text></td></tr><tr><td align="center"/><td align="center"><text><SENT sid="203" pm="."><plain>21 C </plain></SENT>
</text></td><td align="center"><text><SENT sid="204" pm="."><plain>176(91.7%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="205" pm="."><plain>299(88%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="206" pm="."><plain>225(80.4%) </plain></SENT>
</text></td><td align="center"/></tr><tr><td align="center"/><td align="center"><text><SENT sid="207" pm="."><plain>21 T </plain></SENT>
</text></td><td align="center"><text><SENT sid="208" pm="."><plain>16(8.3%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="209" pm="."><plain>41(12%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="210" pm="."><plain>55(19.6%) </plain></SENT>
</text></td><td align="center"/></tr><tr><td colspan="6"><text><SENT sid="211" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="212" pm="."><plain>Genes </plain></SENT>
</text></td><td align="center"><text><SENT sid="213" pm="."><plain>Alleles of SNPs or genetic variants </plain></SENT>
</text></td><td align="center"><text><SENT sid="214" pm="."><plain>Centenarians </plain></SENT>
</text></td><td align="center"><text><SENT sid="215" pm="."><plain>Young controls (&lt; 55 years) </plain></SENT>
</text></td><td align="center"><text><SENT sid="216" pm="."><plain>PC patients (&lt; 55 years) </plain></SENT>
</text></td><td align="center"><text><SENT sid="217" pm="."><plain>P </plain></SENT>
</text></td></tr><tr><td colspan="6"><text><SENT sid="218" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td/><td/><td align="center"><text><SENT sid="219" pm="."><plain>N = 55 males </plain></SENT>
</text></td><td align="center"><text><SENT sid="220" pm="."><plain>N = 125 males </plain></SENT>
</text></td><td align="center"><text><SENT sid="221" pm="."><plain>N = 50 males </plain></SENT>
</text></td><td/></tr><tr><td colspan="6"><text><SENT sid="222" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="223" pm="."><plain>TLR4 </plain></SENT>
</text></td><td align="center"><text><SENT sid="224" pm="."><plain>+896A </plain></SENT>
</text></td><td align="center"><text><SENT sid="225" pm="."><plain>94 (85%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="226" pm="."><plain>235 (94%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="227" pm="."><plain>99 (99%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="228" pm="."><plain>0.001 [54] </plain></SENT>
</text></td></tr><tr><td align="center"/><td align="center"><text><SENT sid="229" pm="."><plain>+896 G </plain></SENT>
</text></td><td align="center"><text><SENT sid="230" pm="."><plain>16 (15%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="231" pm="."><plain>15 (6%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="232" pm="."><plain>1 (1%) </plain></SENT>
</text></td><td align="center"/></tr><tr><td colspan="6"><text><SENT sid="233" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="234" pm="."><plain>Cox-2 </plain></SENT>
</text></td><td align="center"><text><SENT sid="235" pm="."><plain>-765 G </plain></SENT>
</text></td><td align="center"><text><SENT sid="236" pm="."><plain>67 (61%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="237" pm="."><plain>176 (70%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="238" pm="."><plain>77 (77%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="239" pm="."><plain>0.05 </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="240" pm="."><plain>5-Lo </plain></SENT>
</text></td><td align="center"><text><SENT sid="241" pm="."><plain>-765 C </plain></SENT>
</text></td><td align="center"><text><SENT sid="242" pm="."><plain>43 (39%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="243" pm="."><plain>74 (30%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="244" pm="."><plain>23(23%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="245" pm="."><plain>0.0007 </plain></SENT>
</text></td></tr><tr><td align="center"/><td align="center"><text><SENT sid="246" pm="."><plain>-1708 G </plain></SENT>
</text></td><td align="center"><text><SENT sid="247" pm="."><plain>104 (95%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="248" pm="."><plain>223 (89%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="249" pm="."><plain>77 (77%) </plain></SENT>
</text></td><td align="center"/></tr><tr><td align="center"/><td align="center"><text><SENT sid="250" pm="."><plain>-1708A </plain></SENT>
</text></td><td align="center"><text><SENT sid="251" pm="."><plain>6 (5%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="252" pm="."><plain>27 (11%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="253" pm="."><plain>23 (23%) </plain></SENT>
</text></td><td align="center"/></tr><tr><td colspan="6"><text><SENT sid="254" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td/><td/><td align="center"><text><SENT sid="255" pm="."><plain>N = 53 males </plain></SENT>
</text></td><td/><td align="center"><text><SENT sid="256" pm="."><plain>N = 50 males </plain></SENT>
</text></td><td/></tr><tr><td colspan="6"><text><SENT sid="257" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="258" pm="."><plain>CCR5 </plain></SENT>
</text></td><td align="center"><text><SENT sid="259" pm="."><plain>WT </plain></SENT>
</text></td><td align="center"><text><SENT sid="260" pm="."><plain>95 (89.6%) </plain></SENT>
</text></td><td/><td align="center"><text><SENT sid="261" pm="."><plain>97 (97%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="262" pm="."><plain>0.03 [53] </plain></SENT>
</text></td></tr><tr><td align="center"/><td align="center"><text><SENT sid="263" pm="."><plain>Δ32 </plain></SENT>
</text></td><td align="center"><text><SENT sid="264" pm="."><plain>11(10.4%) </plain></SENT>
</text></td><td align="center"/><td align="center"><text><SENT sid="265" pm="."><plain>3(3%) </plain></SENT>
</text></td><td align="center"/></tr><tr><td colspan="6"><text><SENT sid="266" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="267" pm="."><plain>Gene </plain></SENT>
</text></td><td align="center"><text><SENT sid="268" pm="."><plain>Alleles of SNPs or genetic variants </plain></SENT>
</text></td><td align="center"><text><SENT sid="269" pm="."><plain>Centenarians </plain></SENT>
</text></td><td align="center"><text><SENT sid="270" pm="."><plain>Young controls (&lt; 55 years) </plain></SENT>
</text></td><td align="center"><text><SENT sid="271" pm="."><plain>BF patients (30-60 years) </plain></SENT>
</text></td><td align="center"><text><SENT sid="272" pm="."><plain>P </plain></SENT>
</text></td></tr><tr><td colspan="6"><text><SENT sid="273" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td/><td/><td align="center"><text><SENT sid="274" pm="."><plain>N = 42 females </plain></SENT>
</text></td><td align="center"><text><SENT sid="275" pm="."><plain>N = 42 females </plain></SENT>
</text></td><td align="center"><text><SENT sid="276" pm="."><plain>N = 42 females </plain></SENT>
</text></td><td/></tr><tr><td colspan="6"><text><SENT sid="277" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="278" pm="."><plain>TLR4 </plain></SENT>
</text></td><td align="center"><text><SENT sid="279" pm="."><plain>+896A </plain></SENT>
</text></td><td align="center"><text><SENT sid="280" pm="."><plain>81 (96.4%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="281" pm="."><plain>78 (92.9%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="282" pm="."><plain>76 (90.4%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="283" pm="."><plain>0.003 [55] </plain></SENT>
</text></td></tr><tr><td align="center"/><td align="center"><text><SENT sid="284" pm="."><plain>+ 896 G </plain></SENT>
</text></td><td align="center"><text><SENT sid="285" pm="."><plain>3 (3.6%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="286" pm="."><plain>6 (7.1%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="287" pm="."><plain>8 (9.6%) </plain></SENT>
</text></td><td align="center"/></tr></tbody></table></table-wrap></SecTag><p><text><SENT sid="288" pm="."><plain>Our data, showing the relevance of C282Y for women survival to late age, allow adding another piece of evidence to the complex puzzle of genetic and environmental factors involved in control of lifespan in humans. </plain></SENT>
<SENT sid="289" pm="."><plain>The complex interaction of environmental, historical and genetic factors, differently characterizing the various parts of a country, i.e. Italy, likely plays an important role in determining the gender-specific probability of attaining longevity [30,31,33,36]. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="290" pm="."><plain>Role of innate immunity genes in longevity: the paradigmatic case of TLR4, CCR5, COX-2 and 5-LO genes </plain></SENT>
</text></title><p><text><SENT sid="291" pm="."><plain>According to evolutionary ageing theories, most of the parameters influencing immunosenescence appear to be under genetic control [32,37,38]. </plain></SENT>
<SENT sid="292" pm="."><plain>An example is given by the innate immune system, involved in neutralizing infectious agents [39]. </plain></SENT>
<SENT sid="293" pm="."><plain>It plays a beneficial role until the time of reproduction and parental care. </plain></SENT>
<SENT sid="294" pm="."><plain>In old age, a period largely not foreseen by evolution, it can determine an opposite and detrimental effect through chronic inflammatory responses ("antagonistic pleiotropy") [38,40]. </plain></SENT>
<SENT sid="295" pm="."><plain>Genetic pro-/anti-inflammatory variations in innate immune response are, indeed, thought to influence the susceptibility of age-related human diseases, by altering host response to environmental and endogenous stress [41]. </plain></SENT>
<SENT sid="296" pm="."><plain>Thus, they are able to determine a negative or positive control of inflammation, by affecting both interactions between host and microbes and survival of the individual and attainment of longevity. </plain></SENT>
<SENT sid="297" pm="."><plain>Furthermore, they appear both to be responsible, at least in large part, for different men and women strategies to achieve longevity, and to contribute to the preferential sex dimorphism of the age-related diseases [30,31,33]. </plain></SENT>
</text></p><p><text><SENT sid="298" pm="."><plain>From our investigations in Sicilian population, TLR4, CCR5, Cox2, 5-Lo genes can be considered good examples. </plain></SENT>
<SENT sid="299" pm="."><plain>They provide an ideal model to understand the different implications of their genetic variants in the risk of age-related diseases, i.e. atherosclerosis and prostate cancer (PC), and reciprocally in increased chance to attain longevity. </plain></SENT>
</text></p><p><text><SENT sid="300" pm="."><plain>TLR4 gene (number accession of GenBank: <ext-link ext-link-type="gen" xlink:href="NM-138554.1">NM-138554.1</ext-link>) codifies the best understood TLR member involved in recognition of LPS, the prototypic TLR4 ligand, and other exogenous and endogenous (i.e. HSPs, hyaluronic acid, β-defensin-2, ox-LDL, fibronectin and amyloid peptide) ligands. </plain></SENT>
<SENT sid="301" pm="."><plain>TLR4 activation implies a downstream signaling mediated by several intracellular adaptor molecules and the consequent activation of transcription factors, such as NF-kB. </plain></SENT>
<SENT sid="302" pm="."><plain>This determines the production of different pro/anti-inflammatory mediators. </plain></SENT>
<SENT sid="303" pm="."><plain>These lasts, such as IL-10, are produced by the parallel activation of anti-inflammatory pathways to limit the potential tissue damage from excessive activation of the innate immune system [42]. </plain></SENT>
<SENT sid="304" pm="."><plain>SNPs seem to modulate both TLR4 activity and function. </plain></SENT>
<SENT sid="305" pm="."><plain>In human, only two SNPs, +896A/G (Asp299Gly; rs4986790) and +1196 C/T (Thr399Ile; rs4986791), have a frequency &gt; 5%. </plain></SENT>
<SENT sid="306" pm="."><plain>They induce a blunted response to LPS, as first suggested by Arbour et al., and are phenotypically associated to changes in the production of cytokines, principally those carrying the Asp299Gly mutation [43-45]. </plain></SENT>
<SENT sid="307" pm="."><plain>Accordingly, recent literature data suggest the ability of this SNP to modulate the risk of major age-related diseases [42]. </plain></SENT>
</text></p><p><text><SENT sid="308" pm="."><plain>The CCR5 gene (number accession of GenBank: <ext-link ext-link-type="gen" xlink:href="NM-00579">NM-00579</ext-link>) codifies for a G protein-coupled chemokine receptor, which regulates trafficking and effector functions of memory/effector Th1 cells, macrophages, NK cells and immature dendritic cells. </plain></SENT>
<SENT sid="309" pm="."><plain>CCR5 and its ligands are important molecules in viral pathogenesis. </plain></SENT>
<SENT sid="310" pm="."><plain>Recent evidence has also demonstrated the role of CCR5 in a variety of human diseases, ranging from infectious and inflammatory age-related diseases to cancer. </plain></SENT>
<SENT sid="311" pm="."><plain>A notable variant of CCR5 gene is a 32 bp (Δ32) deletion, which causes a frame shift mutation in exon 4 (CCR5Δ32; rs333) and determines stop protein maturation and loss of expression of functional CCR5 receptor [46]. </plain></SENT>
<SENT sid="312" pm="."><plain>Accordingly, it seems to have a protective role against CVD and other age-related diseases, such as PC. </plain></SENT>
<SENT sid="313" pm="."><plain>It, indeed, determines a slower progression of atherogenesis or cancerogenesis as a consequence of an attenuated inflammatory response. </plain></SENT>
</text></p><p><text><SENT sid="314" pm="."><plain>COX-2 gene maps in the 1q25 chromosome and codifies for the Cox-2 enzyme involved in the conversion of arachidonic acid to prostaglandins. </plain></SENT>
<SENT sid="315" pm="."><plain>Polymorphisms regulate its expression and hence prostanoid biosynthesis. </plain></SENT>
<SENT sid="316" pm="."><plain>In particular, it has been identified a guanine to cytosine substitution at position -765 G/C, located within a putative binding site for the transcription factor Sp1, associated to a reduction in the risk of clinical cardiovascular events. </plain></SENT>
<SENT sid="317" pm="."><plain>COX-2 is expressed at low levels in most tissues, but its expression enhances under inflammatory stimuli and in inflammatory age-related processes, i.e. atherosclerosis, rheumatoid diseases and cancer [47]. </plain></SENT>
</text></p><p><text><SENT sid="318" pm="."><plain>The 5-LO gene maps in the chromosome 10q11.2 and codifies the 5-Lo enzyme involved in the synthesis of LTs. </plain></SENT>
<SENT sid="319" pm="."><plain>The 5-LO pathway has been associated to atherosclerosis in mouse and human histological studies. </plain></SENT>
<SENT sid="320" pm="."><plain>Several SNPs have been described. </plain></SENT>
<SENT sid="321" pm="."><plain>In particular, the - 1708 G/A, -1761 G/A and 21 C/T SNPs in promoter region and exon-1 of 5-LO gene modify the gene transcription or the putative protein [47]. </plain></SENT>
</text></p><p><text><SENT sid="322" pm="."><plain>An over-expression of anti-inflammatory CCR5Δ32 variant, +896 G (299Gly) TLR4 allele, -765 C Cox-2 allele, -1708 G and 21 C 5-Lo alleles characterizes male Sicilian centenarians (Table 3) [47-49]. </plain></SENT>
<SENT sid="323" pm="."><plain>So, male centenarians are people who seem genetically equipped for defeating major age-related diseases. </plain></SENT>
<SENT sid="324" pm="."><plain>They present SNPs in the immune system genome (i.e. SNPs or other genetic variations, located within the promoter regions of pro-inflammatory cytokines) which, regulating the immune-inflammatory responses, seem to be associated to longevity [30-32]. </plain></SENT>
<SENT sid="325" pm="."><plain>Furthermore, centenarians are characterized by marked delay or escape from age-associated diseases, responsible for the high mortality in earlier ages. </plain></SENT>
<SENT sid="326" pm="."><plain>In particular, it has been demonstrated that centenarian offspring have an increased likelihood of surviving to 100 years and show a reduced prevalence of age associated diseases, such as CVD, and lower prevalence of CVD risk factors [1,30-32,50] Thus, genes involved in CVD may play an opposite role in human male longevity. </plain></SENT>
<SENT sid="327" pm="."><plain>Our data in male Sicilian population confirm this suggestion and emphasize the role of antagonistic pleiotropy in ageing and longevity [51,52]. </plain></SENT>
<SENT sid="328" pm="."><plain>A high frequency of proinflammatory CCR5wt variant, +896A TLR4 allele, -765 G Cox-2 allele, 1708A and 21 T 5-Lo alleles characterizes male Sicilian patients affected by MI (Table 3) [47-49]. </plain></SENT>
<SENT sid="329" pm="."><plain>In a recent study, we also found a similar overexpression of these proinflammatory SNPs in male Sicilian patients affected by PC (Table 3). </plain></SENT>
<SENT sid="330" pm="."><plain>Opposite data were obtained in male centenarians [53,54]. </plain></SENT>
</text></p><p><text><SENT sid="331" pm="."><plain>In contrast, female Sicilian centenarians have a different frequency of the alleles of +896A/G TLR4 SNP than that observed in male Sicilian centenarians. </plain></SENT>
<SENT sid="332" pm="."><plain>In particular, female Sicilian centenarians show an over-expression of the pro-inflammatory +896A TLR4 allele respect to female patients affected by Boutonneuse fever and age-matched controls (Table 3) [55]. </plain></SENT>
</text></p><p><text><SENT sid="333" pm="."><plain>On the other hand, pro-inflammatory responses are evolutionary programmed to resist fatal infections. </plain></SENT>
<SENT sid="334" pm="."><plain>Thus, it is not surprising that the genetic background of people that survive to an advanced age may be protective against infections [55]. </plain></SENT>
</text></p><p><text><SENT sid="335" pm="."><plain>Based on our data, we suggest that Sicilian men and women may follow different trajectories to reach longevity. </plain></SENT>
<SENT sid="336" pm="."><plain>For men it might be more important to control atherogenesis and cancerogenesis, whereas for women it might be more important to control infectious diseases [30,31]. </plain></SENT>
</text></p><p><text><SENT sid="337" pm="."><plain>In order to confirm our suggestions on the biological effects of +896A/G TLR4 SNP and its role in the pathophysiology of age-related diseases studied (i.e. MI and PC) and longevity, we recently assessed the levels of IL-6, TNF-α, IL-10 and eicosanoids in LPS-stimulated whole blood samples from 50 young healthy Sicilians, screened for the presence of this SNP. </plain></SENT>
<SENT sid="338" pm="."><plain>Both pro-inflammatory cytokines and eicosanoids were significantly lower in carriers bearing the +896 G TLR4 allele, whereas the anti-inflammatory IL-10 values were higher [56]. </plain></SENT>
<SENT sid="339" pm="."><plain>This suggests the ability of the +896 G TLR4 allele to mediate a better control of inflammatory responses induced by chronic stimuli, so likely decreasing the effects of atherogenetic damage and prostate carcinogens. </plain></SENT>
</text></p><p><text><SENT sid="340" pm="."><plain>On the basis of data reported herein, some suggestions can be drawn. </plain></SENT>
<SENT sid="341" pm="."><plain>First, pathogen load, by interacting with the host genotype, determines the type and intensity of inflammatory responses, according to the pro-inflammatory status and tissue injury, implicated in the patho-physiology of major age-related diseases. </plain></SENT>
<SENT sid="342" pm="."><plain>Second, adequate control of inflammatory response might reduce the risk of these diseases, and, reciprocally, might increase the chance of extended survival in an environment with reduced pathogen load. </plain></SENT>
<SENT sid="343" pm="."><plain>Accordingly, a higher frequency of the anti-inflammatory +896 G TLR4 allele has been observed in centenarians [49]. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="344" pm="."><plain>Cytokine profile: a biomarker for successful ageing </plain></SENT>
</text></title><p><text><SENT sid="345" pm="."><plain>Cytokines are considered key players in maintaining lymphocyte homeostasis [57,58]. </plain></SENT>
<SENT sid="346" pm="."><plain>Their function is not limited to induce response after an immune insult, but they can modulate the nature of response (cytotoxic, humoral, cell mediated, inflammatory or allergic) or, in contrast, they may cause non-responsiveness and active immune suppression [58]. </plain></SENT>
<SENT sid="347" pm="."><plain>Furthermore, sequence variations in several cytokine genes, such as IFN-γ and IL-10 genes, have been demonstrated to be associated with successful ageing and longevity [58]. </plain></SENT>
<SENT sid="348" pm="."><plain>On the other hand, individual changes in type and intensity of immune response affecting life span expectancy and health ageing seem to have a genetic component. </plain></SENT>
<SENT sid="349" pm="."><plain>A well-preserved immune function characterizing the successful ageing has been found in centenarians [38]. </plain></SENT>
<SENT sid="350" pm="."><plain>Recent evidence suggests that centenarians seem to be genetically equipped gene polymorphism for overcame the major age-related diseases and polymorphisms in immune system genes involved in regulation of immune responses have been found associated to longevity. </plain></SENT>
<SENT sid="351" pm="."><plain>In particular, associations between both cytokine gene polymorphisms and longevity, and differential gender longevity in males and females, and reciprocally to age-related diseases have been demonstrated [38,58,59]. </plain></SENT>
</text></p><p><text><SENT sid="352" pm="."><plain>Our data in Sicilian population confirm these associations and suggest that differences in the genetic regulation of immune inflammatory processes might explain the reason why some people but not others develop age-related diseases and why some develop a greater inflammatory response than others. </plain></SENT>
<SENT sid="353" pm="."><plain>In particular, this suggestion seems to be suitable for some SNPs in IFN-γ and IL-10 genes (Table 4) [60-63]. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="T4" position="float"><label>Table 4</label><caption><p><text><SENT sid="354" pm="."><plain>Cytokine data from our studies in Sicilian population </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="6"><text><SENT sid="355" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="356" pm="."><plain>Gene </plain></SENT>
</text></td><td align="center"><text><SENT sid="357" pm="."><plain>Genotypes </plain></SENT>
</text></td><td align="center"><text><SENT sid="358" pm="."><plain>Centenarians </plain></SENT>
</text></td><td align="center"><text><SENT sid="359" pm="."><plain>Young controls (&lt; 55 years) </plain></SENT>
</text></td><td/><td align="center"><text><SENT sid="360" pm="."><plain>P </plain></SENT>
</text></td></tr><tr><td colspan="6"><text><SENT sid="361" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td/><td/><td align="center"><text><SENT sid="362" pm="."><plain>N = 31 males </plain></SENT>
</text></td><td align="center"><text><SENT sid="363" pm="."><plain>N = 161 males </plain></SENT>
</text></td><td/><td/></tr><tr><td colspan="6"><text><SENT sid="364" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="365" pm="."><plain>IL-10 </plain></SENT>
</text></td><td align="center"><text><SENT sid="366" pm="."><plain>-1082GG </plain></SENT>
</text></td><td align="center"><text><SENT sid="367" pm="."><plain>18 (58%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="368" pm="."><plain>55 (34%) </plain></SENT>
</text></td><td/><td align="center"><text><SENT sid="369" pm="."><plain>&lt; 0.025 [61] </plain></SENT>
</text></td></tr><tr><td align="center"/><td align="center"><text><SENT sid="370" pm="."><plain>-1083GA </plain></SENT>
</text></td><td align="center"><text><SENT sid="371" pm="."><plain>9 (29%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="372" pm="."><plain>88 (55%) </plain></SENT>
</text></td><td align="center"/><td align="center"/></tr><tr><td/><td align="center"><text><SENT sid="373" pm="."><plain>-1082AA </plain></SENT>
</text></td><td align="center"><text><SENT sid="374" pm="."><plain>4 (13%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="375" pm="."><plain>18 (11%) </plain></SENT>
</text></td><td/><td/></tr><tr><td colspan="6"><text><SENT sid="376" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td/><td/><td align="center"><text><SENT sid="377" pm="."><plain>N = 72 males </plain></SENT>
</text></td><td align="center"><text><SENT sid="378" pm="."><plain>N = 115 males </plain></SENT>
</text></td><td/><td/></tr><tr><td colspan="6"><text><SENT sid="379" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="380" pm="."><plain>IL-10 </plain></SENT>
</text></td><td align="center"><text><SENT sid="381" pm="."><plain>-1082GG </plain></SENT>
</text></td><td align="center"><text><SENT sid="382" pm="."><plain>33 (46%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="383" pm="."><plain>32(28%) </plain></SENT>
</text></td><td/><td align="center"><text><SENT sid="384" pm="."><plain>0.019 [62] </plain></SENT>
</text></td></tr><tr><td align="center"/><td align="center"><text><SENT sid="385" pm="."><plain>-1083GA </plain></SENT>
</text></td><td align="center"><text><SENT sid="386" pm="."><plain>34(47%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="387" pm="."><plain>64(56%) </plain></SENT>
</text></td><td align="center"/><td align="center"/></tr><tr><td align="center"/><td align="center"><text><SENT sid="388" pm="."><plain>-1082AA </plain></SENT>
</text></td><td align="center"><text><SENT sid="389" pm="."><plain>5(7%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="390" pm="."><plain>19(16%) </plain></SENT>
</text></td><td align="center"/><td align="center"/></tr><tr><td colspan="6"><text><SENT sid="391" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td/><td/><td align="center"><text><SENT sid="392" pm="."><plain>Centenarians </plain></SENT>
</text></td><td align="center"><text><SENT sid="393" pm="."><plain>Young controls (&lt; 55 years) </plain></SENT>
</text></td><td align="center"><text><SENT sid="394" pm="."><plain>MI patients (&lt; 55 years) </plain></SENT>
</text></td><td align="center"><text><SENT sid="395" pm="."><plain>P </plain></SENT>
</text></td></tr><tr><td colspan="6"><text><SENT sid="396" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td/><td/><td align="center"><text><SENT sid="397" pm="."><plain>N = 52 males </plain></SENT>
</text></td><td align="center"><text><SENT sid="398" pm="."><plain>N = 110 males </plain></SENT>
</text></td><td align="center"><text><SENT sid="399" pm="."><plain>N = 90 males </plain></SENT>
</text></td><td/></tr><tr><td colspan="6"><text><SENT sid="400" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="401" pm="."><plain>IL-10 </plain></SENT>
</text></td><td align="center"><text><SENT sid="402" pm="."><plain>-1082GG </plain></SENT>
</text></td><td align="center"><text><SENT sid="403" pm="."><plain>25 (48.1%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="404" pm="."><plain>26(23.6%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="405" pm="."><plain>17 (18.9%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="406" pm="."><plain>0.003 [63] </plain></SENT>
</text></td></tr><tr><td align="center"/><td align="center"><text><SENT sid="407" pm="."><plain>-1083GA </plain></SENT>
</text></td><td align="center"><text><SENT sid="408" pm="."><plain>23 (44.2%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="409" pm="."><plain>56 (50.9%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="410" pm="."><plain>29 (32.2%) </plain></SENT>
</text></td><td align="center"/></tr><tr><td align="center"/><td align="center"><text><SENT sid="411" pm="."><plain>-1082AA </plain></SENT>
</text></td><td align="center"><text><SENT sid="412" pm="."><plain>6(11.5%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="413" pm="."><plain>28 (25.5%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="414" pm="."><plain>44 (48.9%) </plain></SENT>
</text></td><td align="center"/></tr><tr><td colspan="6"><text><SENT sid="415" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="center"><text><SENT sid="416" pm="."><plain>Genes </plain></SENT>
</text></td><td align="center"><text><SENT sid="417" pm="."><plain>Alleles of SNP </plain></SENT>
</text></td><td align="center"><text><SENT sid="418" pm="."><plain>Centenarians </plain></SENT>
</text></td><td align="center"><text><SENT sid="419" pm="."><plain>Young controls (&lt; 55 years) </plain></SENT>
</text></td><td/><td align="center"><text><SENT sid="420" pm="."><plain>P </plain></SENT>
</text></td></tr><tr><td/><td/><td align="center"><text><SENT sid="421" pm="."><plain>N = 142 females </plain></SENT>
</text></td><td align="center"><text><SENT sid="422" pm="."><plain>N = 90 females </plain></SENT>
</text></td><td/><td/></tr><tr><td align="center"><text><SENT sid="423" pm="."><plain>IFN-γ </plain></SENT>
</text></td><td align="center"><text><SENT sid="424" pm="."><plain>+874 T </plain></SENT>
</text></td><td align="center"><text><SENT sid="425" pm="."><plain>102 (35.9%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="426" pm="."><plain>85 (47.2%) </plain></SENT>
</text></td><td/><td align="center"><text><SENT sid="427" pm="."><plain>0.02 [60] </plain></SENT>
</text></td></tr><tr><td align="center"/><td align="center"><text><SENT sid="428" pm="."><plain>+ 874A </plain></SENT>
</text></td><td align="center"><text><SENT sid="429" pm="."><plain>182 (64.1%) </plain></SENT>
</text></td><td align="center"><text><SENT sid="430" pm="."><plain>95 (52.8%) </plain></SENT>
</text></td><td align="center"/><td align="center"/></tr></tbody></table></table-wrap></SecTag><p><text><SENT sid="431" pm="."><plain>IFN-γ gene codifies for a cytokine involved in defense against viruses and intracellular pathogens, and in induction of immune mediated inflammatory responses. </plain></SENT>
<SENT sid="432" pm="."><plain>Its production is genetically regulated. </plain></SENT>
<SENT sid="433" pm="."><plain>A variable length CA repeat sequence in the first intron of IFN-γ gene has been described to be associated with high IFN-γ production. </plain></SENT>
<SENT sid="434" pm="."><plain>Furthermore, a SNP, T to A (+874 T/A), at 59 end of the CA repeat region has been described and T presence has been related to high-producing microsatellite allele 2. </plain></SENT>
<SENT sid="435" pm="."><plain>This SNP coincides with a putative NF-κB binding site, which might have functional consequences for transcription of IFN-γ gene. </plain></SENT>
<SENT sid="436" pm="."><plain>Thus, this SNP might directly influence IFN-γ production levels associated to CA microsatellite marker [60]. </plain></SENT>
</text></p><p><text><SENT sid="437" pm="."><plain>IL-10 gene codifies for IL-10 cytokine. </plain></SENT>
<SENT sid="438" pm="."><plain>IL-10 is produced by macrophages, T and B cells. </plain></SENT>
<SENT sid="439" pm="."><plain>It is one of the major immune-regulatory cytokines, usually considered to mediate potent down-regulation of inflammatory responses. </plain></SENT>
<SENT sid="440" pm="."><plain>IL-10 production, independently on interaction with other cytokine gene products, is generally controlled by several polymorphic elements in the 5' flanking region of IL-10 gene. </plain></SENT>
<SENT sid="441" pm="."><plain>Multiple SNPs have been identified in human IL-10 5' flanking region and some of these (i.e. -592, -819, -1082) combine with microsatellite alleles to form haplotype associated with differential IL-10 production. </plain></SENT>
<SENT sid="442" pm="."><plain>These three SNPs in the IL-10 proximal gene region (considered potential targets for transcription regulating factors) might be involved in genetic control of IL-10 production, even if contrasting literature data have been reported. </plain></SENT>
<SENT sid="443" pm="."><plain>In particular, the homozygous -1082GG genotype seems to be associated with higher IL-10 production respect to G/A heterozygous and AA homozygous genotypes. </plain></SENT>
<SENT sid="444" pm="."><plain>Furthermore, this SNP seems to be functionally relevant. </plain></SENT>
<SENT sid="445" pm="."><plain>It has been demonstrated that -1082 A carriers (low producers) seem likely develop a major number of chronic inflammatory diseases [61-63]. </plain></SENT>
</text></p><p><text><SENT sid="446" pm="."><plain>Our results demonstrated an increase of subjects carrying the -1082 G IL-10 allele in centenarian men [61-63]. </plain></SENT>
<SENT sid="447" pm="."><plain>This allele is associated to significantly increased IL-10 production. </plain></SENT>
<SENT sid="448" pm="."><plain>Conversely, we observed that the frequency of -1082A allele, associated to low IL-10 production, was significantly higher in MI patients (Table 4) [63]. </plain></SENT>
<SENT sid="449" pm="."><plain>Thus, high IL-10 production seems to be protective vs. MI and a possible biomarker for longevity. </plain></SENT>
<SENT sid="450" pm="."><plain>People with exceptional longevity have genetic factors (i.e. protective factors for CVD) that modulate ageing processes [63]. </plain></SENT>
<SENT sid="451" pm="."><plain>This supports the opinion that a genetic background protective against CVD is a component of longevity. </plain></SENT>
<SENT sid="452" pm="."><plain>On the other hand, our immune system has evolved to control pathogens and pro-inflammatory responses are likely programmed by evolution to resist fatal infections. </plain></SENT>
<SENT sid="453" pm="."><plain>From this prospective, low IL-10 production is correlated with increased resistance to pathogens. </plain></SENT>
<SENT sid="454" pm="."><plain>In older ages not evolutionally programmed, increased IL-10 levels might better control inflammatory responses induced by chronic vessel damage and reduce the risk for atherogenetic complications. </plain></SENT>
<SENT sid="455" pm="."><plain>These conditions might permit to achieve exceptional ages in an environmental with a reduced pathogen load [63]. </plain></SENT>
</text></p><p><text><SENT sid="456" pm="."><plain>In contrast, female Sicilian centenarians are characterized by an over-expression of +874 INF-γ allele (Table 4) [60]. </plain></SENT>
<SENT sid="457" pm="."><plain>The INF-γ production is also influenced by hormonal control fundamentally mediated by 17β extradiol. </plain></SENT>
<SENT sid="458" pm="."><plain>Hormonal regulation of this cytokine has been suggested to modulate, in part, the ability of estrogens to potentiate many types of immune responses and to influence the disproportionate susceptibility of women for immune-inflammatory diseases. </plain></SENT>
<SENT sid="459" pm="."><plain>Thus, gene variants representing genetic advantage for one gender might not be reciprocally relevant for the other gender in terms of successful or unsuccessful ageing [60]. </plain></SENT>
</text></p><p><text><SENT sid="460" pm="."><plain>The data from Sicilian investigation add another piece to complex puzzle of genetic and environmental factors involved in the control of life span expectancy in humans. </plain></SENT>
<SENT sid="461" pm="."><plain>Studies on cytokine gene SNPs may promise to individuate a complex network of trans-inactive genes able to influence the type and strength of immune responses to environmental stressors, and as final result, conditioning individual life expectancy [60-63]. </plain></SENT>
<SENT sid="462" pm="."><plain>On the other hand, we recently suggested the possibility to use cytokine profile as biomarker of successful ageing, by evaluating through Lumines technology cytokine serum levels in 44 Sicilian nonagenarians and 79 control subjects (aged between 30 and 50 years old) [64]. </plain></SENT>
<SENT sid="463" pm="."><plain>IFN-γ and IL-2 levels are unmodified, suggesting a substantial maintenance of relevant T functions. </plain></SENT>
<SENT sid="464" pm="."><plain>In addition, a significant increase of IL-12 serum levels was observed. </plain></SENT>
<SENT sid="465" pm="."><plain>This condition might be associated with the increase of NK cell function with ageing. </plain></SENT>
<SENT sid="466" pm="."><plain>Furthermore, an increase of IL-13 and a reduction of IL-4 were found. </plain></SENT>
<SENT sid="467" pm="."><plain>Thus, the maintenance of some effector's mechanisms of immune-response characterizes advanced ages. </plain></SENT>
<SENT sid="468" pm="."><plain>From a general point of view, our data firstly confirm the age-related remodeling of cytokine network. </plain></SENT>
<SENT sid="469" pm="."><plain>Furthermore, they underline the presence of unchanged levels of some crucial cytokines useful in preserving key immune function in long-living persons [64]. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="470" pm="."><plain>Future perspectives </plain></SENT>
</text></title><p><text><SENT sid="471" pm="."><plain>The ageing process and longevity are multi-factorial events. </plain></SENT>
<SENT sid="472" pm="."><plain>Genetic, epigenetic, stochastic and environmental factors seem to have a crucial role in ageing and longevity. </plain></SENT>
<SENT sid="473" pm="."><plain>Epigenetic is associated to ageing, as shown in the major number of studies. </plain></SENT>
<SENT sid="474" pm="."><plain>In particular, ageing is associated to a global loss of methylation state [65]. </plain></SENT>
<SENT sid="475" pm="."><plain>In addition, tissue-dependent age-related hypermetylation of specific DNA regions have been observed. </plain></SENT>
<SENT sid="476" pm="."><plain>Thus, it can be concluded that epigenetic age-related modification are stochastic and no linked to specific DNA region, while epigenetic changes linked to specific environmental stimuli are limited in specific DNA region [66,67]. </plain></SENT>
<SENT sid="477" pm="."><plain>These observations have led to address the research on epigenomics and its implication in ageing and longevity. </plain></SENT>
</text></p><p><text><SENT sid="478" pm="."><plain>Epigenomics is the systematic study of the global gene expression changes due to epigenetic processes, but not to DNA base sequence changes. </plain></SENT>
<SENT sid="479" pm="."><plain>Epigenetic processes consist in heritable modification that result in a selective gene expression or repression and consequently in phenotype changes [68]. </plain></SENT>
<SENT sid="480" pm="."><plain>These changes include nucleosome positioning, post-translation histone modifications, action of small RNAs, DNA replication timing, heterochromatinization and DNA methylation [69]. </plain></SENT>
<SENT sid="481" pm="."><plain>This last one consists in the addition of a methyl group (-CH3) in the carbon 5 of cytosines, particularly in the CpG dinucleotide. </plain></SENT>
<SENT sid="482" pm="."><plain>This condition particularly concerns the CpG islands (CpGIs), located at the regulatory site of gene promoter regions. </plain></SENT>
<SENT sid="483" pm="."><plain>Methylation rate is associated to transcriptional regulation. </plain></SENT>
<SENT sid="484" pm="."><plain>In particular, gene silencing is associated to increase of -CH3 groups on DNA, conversely hypometylation of CGIs is associated to an open chromatin state resulting in gene expression [70]. </plain></SENT>
</text></p><p><text><SENT sid="485" pm="."><plain>Although the association between ageing and epigenetic is a real evidence, processes involved are not clear. </plain></SENT>
<SENT sid="486" pm="."><plain>Certainly, the nutrition affects epigenetic modifications. </plain></SENT>
<SENT sid="487" pm="."><plain>Nutrients can be active on specific sites. </plain></SENT>
<SENT sid="488" pm="."><plain>For example, vitamin B12, vitamin B6, riboflavin, methionine, choline and betaine, well known as folates, regulate levels of S-adenosylmethionine and S-adenosylhomocysteine, donor of -CH3 group and methyltransferase inhibitor respectively [71]. </plain></SENT>
<SENT sid="489" pm="."><plain>Curcumin, resveratrol, polyphenols and flavonoids, phytoestrogen, and lycopene are also considered key nutritional factors both for regulation of enzyme involved in acetylation and deacetylation mechanism and for one-carbon metabolism [71,72]. </plain></SENT>
<SENT sid="490" pm="."><plain>A diet rich in vegetables and fruit, such as Mediterranean diet, may contain these nutrients. </plain></SENT>
<SENT sid="491" pm="."><plain>Sicilian centenarians are characterized to observe this kind of diet, as we reported [73]. </plain></SENT>
<SENT sid="492" pm="."><plain>Since genetic and environmental factors contribute to longevity, it may suggest that epigenetic events associated to the modifications diet-induced are very important for successful ageing processes. </plain></SENT>
<SENT sid="493" pm="."><plain>Furthermore, several literature data reported a possible link between epigenetic and several age-related diseases, such as cancer, metabolic syndrome, diabetes and neurodegenerative disorders. </plain></SENT>
<SENT sid="494" pm="."><plain>Stable propagation of gene expression from cell to cell during disease pathogenesis is regulated by epigenetic mechanisms. </plain></SENT>
<SENT sid="495" pm="."><plain>For example, during the diabetes onset epigenetic changes act on insulin and insulin metabolism regulating the gene coding [74]. </plain></SENT>
<SENT sid="496" pm="."><plain>In particular, a recent study has demonstrated that human insulin gene and mouse insulin 2 gene expression are under control of epigenetic changes in CpGIs. </plain></SENT>
<SENT sid="497" pm="."><plain>Insulin non expressing cells are, indeed, methylated in the promoter region of insulin coding gene, while insulin expressing cells are completely demethylated in the same site resulting in insulin gene expression [75]. </plain></SENT>
<SENT sid="498" pm="."><plain>Another study on monozygotic twin has demonstrated that insulin resistance is also under control of DNA methylation [76]. </plain></SENT>
<SENT sid="499" pm="."><plain>Alterations in insulin pathway are known to be involved in metabolic disease, such as metabolic syndrome, insulin resistance and type 2 diabetes. </plain></SENT>
<SENT sid="500" pm="."><plain>Recent data also support the existence of a correlation between these alterations and Alzheimer's disease. </plain></SENT>
</text></p><p><text><SENT sid="501" pm="."><plain>In the light of these observations, the purpose of our future studies will be to evaluate the weight of epigenetic changes in ageing and longevity, using centenarians as super-controls. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="ABBR"><sec><title><text><SENT sid="502" pm="."><plain>Abbreviations </plain></SENT>
</text></title><p><text><SENT sid="503" pm="."><plain>AD: Alzheimer's disease; BF: Boutonnese fever; CCR5: CC chemokine receptor 5; COX-2: Cyclo-oxygenase 2; CRP: C reactive protein; CVD: Cardiovascular disease; HSPs: Heat-shock proteins; INF-γ: Interferon- γ; IL-6: Interleukin-6; IL-10: Interleukin-10; 5-LO: 5-lipoxygenase; LPS: Lipopolysaccharide; LTs: Leukotrienes; MI: Myocardial infarction; ox-LDL: Oxidized-Low Density Lipoproteins; PC: Prostate cancer; PGs: Prostaglandins; SNPs: Single nucleotide polymorphisms; TLR4: Toll-like-receptor-4; TNF-α: Tumor necrosis factor-α. </plain></SENT>
</text></p></sec></SecTag><SecTag type="COMP_INT"><sec><title><text><SENT sid="504" pm="."><plain>Competing interests </plain></SENT>
</text></title><p><text><SENT sid="505" pm="."><plain>The authors declare that they have no competing interests. </plain></SENT>
</text></p></sec></SecTag><SecTag type="AUTH_CONT"><sec><title><text><SENT sid="506" pm="."><plain>Authors' contributions </plain></SENT>
</text></title><p><text><SENT sid="507" pm="."><plain>CRB, GA, SB, MB, AM and GCR wrote the first draft. </plain></SENT>
<SENT sid="508" pm="."><plain>Subsequent drafts were written by CRB, who had the overall supervision of the review processing. </plain></SENT>
<SENT sid="509" pm="."><plain>All authors edited the paper and approved its final version. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="ACK_FUND"><sec><title>Acknowledgements</title><p><text4fund><text><SENT sid="510" pm="."><plain>GA, AM, LV are PhD students and SB is a PhD candidate of Pathobiology PhD course (directed by Prof Calogero Caruso) at Palermo University and this paper is submitted in partial fulfillment of requirement for their PhD degree. </plain></SENT>
</text></text4fund></p></sec></SecTag><SecTag type="REF"><ref-list><ref id="B1"><text><SENT sid="511" pm="."><plain>TerryDFWilcoxMAMcCormickMAPenningtonJYSchoenhofenEAAndersenSLPerlsTTLower all-cause, cardiovascular, and cancer mortality in centenarians' offspringJ Am Geriatr Soc2004522074207610.1111/j.1532-5415.2004.52561.x15571545 </plain></SENT>
</text></ref><ref id="B2"><text><SENT sid="512" pm="."><plain>TerryDFMcCormickMAndersenSPenningtonJSchoenhofenEPalaimaEBauseroMOgawaKPerlsTTAseaACardiovascular disease delay in centenarian offspring: role of heat shock proteinsAnn N Y Acad Sci2004101950250510.1196/annals.1297.09215247074 </plain></SENT>
</text></ref><ref id="B3"><text><SENT sid="513" pm="."><plain>BarzilaiNGabrielyIGabrielyMIankowitzNSorkinJDOffspring of centenarians have a favorable lipid profileJ Am Geriatr Soc200149767910.1046/j.1532-5415.2001.49013.x11207846 </plain></SENT>
</text></ref><ref id="B4"><text><SENT sid="514" pm="."><plain>RoseGPassarinoGScornaienchiVRomeoGDatoSBellizziDMariVFeracoEMalettaRBruniAFranceschiCDe BenedictisGThe mitochondrial DNA control region shows genetically correlated levels of heteroplasmy in leukocytes of centenarians and their offspringBMC Genomics2007829310.1186/1471-2164-8-29317727699 </plain></SENT>
</text></ref><ref id="B5"><text><SENT sid="515" pm="."><plain>PawelecGAkbarACarusoCSolanaRGrubeck-LoebensteinBWikbyAHuman immunosenescence: is it infectious?Immunol Rev200520525726810.1111/j.0105-2896.2005.00271.x15882359 </plain></SENT>
</text></ref><ref id="B6"><text><SENT sid="516" pm="."><plain>ChidrawarSKhanNWeiWMcLarnonASmithNNayakLMossPCytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individualsClin Exp Immunol200915542343210.1111/j.1365-2249.2008.03785.x19220832 </plain></SENT>
</text></ref><ref id="B7"><text><SENT sid="517" pm="."><plain>DerhovanessianELarbiAPawelecGBiomarkers of human immunosenescence: impact of Cytomegalovirus infectionCurr Opin Immunol20092144044510.1016/j.coi.2009.05.01219535233 </plain></SENT>
</text></ref><ref id="B8"><text><SENT sid="518" pm="."><plain>DerhovanessianEMaierABBeckRJahnGHähnelKSlagboomPEde CraenAJWestendorpRGPawelecGHallmark features of immunosenescence are absent in familial longevityImmunol20101854618462410.4049/jimmunol.1001629 </plain></SENT>
</text></ref><ref id="B9"><text><SENT sid="519" pm="."><plain>Colonna RomanoGBulatiMAquinoAScialabbaGCandoreGLioDMottaMMalaguarneraMCarusoCB cells in the aged: CD27, CD5 and CD40 expressionMech Ageing Dev200312438939310.1016/S0047-6374(03)00013-712714244 </plain></SENT>
</text></ref><ref id="B10"><text><SENT sid="520" pm="."><plain>Colonna RomanoGCossarizzaAAquinoAScialabbaGBulatiMLioDCandoreGDi LorenzoGFradàGCarusoCAge- and gender-related values of lymphocyte subsets in subjects from northern and southern ItalyArch Gerontol Geriatr (Suppl)200289910714764380 </plain></SENT>
</text></ref><ref id="B11"><text><SENT sid="521" pm="."><plain>ListìFCandoreGModicaMARussoMADi LorenzoGEsposito-PellitteriMColonna RomanoGAquinoABulatiMLioDFranceschiCCarusoCA study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescenceAnn N Y Acad Sci2006108948749510.1196/annals.1386.01317261791 </plain></SENT>
</text></ref><ref id="B12"><text><SENT sid="522" pm="."><plain>CandoreGDi LorenzoGMansuetoPMellusoMFradàGLi VecchiMEsposito PellitteriMDragoADi SalvoACarusoCPrevalence of organ-specific and non organ-specific autoantibodies in healthy centenariansMech Ageing Dev19979418319010.1016/S0047-6374(96)01845-39147370 </plain></SENT>
</text></ref><ref id="B13"><text><SENT sid="523" pm="."><plain>Colonna-RomanoGBulatiMAquinoAVitelloSLioDCandoreGCarusoCB cell immunosenescence in the elderly and in centenariansRejuvenation Res20081143343910.1089/rej.2008.066418442327 </plain></SENT>
</text></ref><ref id="B14"><text><SENT sid="524" pm="."><plain>Colonna-RomanoGBulatiMAquinoAPellicanòMVitelloSLioDCandoreGCarusoCA double-negative (IgD-CD27-) B cell population is increased in the peripheral blood of elderly peopleMech Ageing Dev20091301068169010.1016/j.mad.2009.08.00319698733 </plain></SENT>
</text></ref><ref id="B15"><text><SENT sid="525" pm="."><plain>BulatiMBuffaSCandoreGCarusoCDunn-WaltersDKPellicanòMWuYCColonna RomanoGB cells and immunosenescence: a focus on IgG+IgD-CD27- (DN) B cells in aged humansAgeing Res Rev20111027428410.1016/j.arr.2010.12.00221185406 </plain></SENT>
</text></ref><ref id="B16"><text><SENT sid="526" pm="."><plain>BuffaSBulatiMPellicanòMDunn-WaltersDKWuYCCandoreGVitelloSCarusoCColonna-RomanoGB cell immunosenescence: different features of naive and memory B cells in elderlyBiogerontology20111247348310.1007/s10522-011-9353-421879287 </plain></SENT>
</text></ref><ref id="B17"><text><SENT sid="527" pm="."><plain>WeiCAnolikJCappioneAZhengBPugh-BernardABrooksJLeeEHMilnerECSanzIA new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosusJ Immunol20071786624663317475894 </plain></SENT>
</text></ref><ref id="B18"><text><SENT sid="528" pm="."><plain>SanzIWeiCLeeFEAnolikJPhenotypic and functional heterogeneity of human memory B cellsSemin Immunol2008201678210.1016/j.smim.2007.12.00618258454 </plain></SENT>
</text></ref><ref id="B19"><text><SENT sid="529" pm="."><plain>CagigiADuLDangLVGrutzmeierSAtlasAChiodiFPan-HammarströmQNilssonACD27(-) B-cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infectionPLoS One200945e542710.1371/journal.pone.000542719412542 </plain></SENT>
</text></ref><ref id="B20"><text><SENT sid="530" pm="."><plain>Colonna-RomanoGBuffaSBulatiMCandoreGLioDPellicanòMVastoSCarusoCB cells compartment in centenarian offspring and old peopleCurr Pharm Des20101660460810.2174/13816121079088375020388070 </plain></SENT>
</text></ref><ref id="B21"><text><SENT sid="531" pm="."><plain>FrascaDRileyRLBlombergBBHumoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humansSemin Immunol200517537838410.1016/j.smim.2005.05.00515996480 </plain></SENT>
</text></ref><ref id="B22"><text><SENT sid="532" pm="."><plain>Dunn-WaltersDKAdemokunAAB cell repertoire and ageingCurr Opin Immunol201022451452010.1016/j.coi.2010.04.00920537880 </plain></SENT>
</text></ref><ref id="B23"><text><SENT sid="533" pm="."><plain>CancroMPHaoYScholzJLRileyRLFrascaDDunn-WaltersDKBlombergBBB cells and aging: molecules and mechanismsTrends Immunol200930731331810.1016/j.it.2009.04.00519540810 </plain></SENT>
</text></ref><ref id="B24"><text><SENT sid="534" pm="."><plain>KumarRBurnsEAAge-related decline in immunity: implications for vaccine responsivenessExpert Rev Vaccines20087446747910.1586/14760584.7.4.46718444893 </plain></SENT>
</text></ref><ref id="B25"><text><SENT sid="535" pm="."><plain>GibsonKLWuYCBarnettYDugganOVaughanRKondeatisENilssonBOWikbyAKiplingDDunn-WaltersDKB-cell diversity decreases in old age and is correlated with poor health statusAging Cell200981182510.1111/j.1474-9726.2008.00443.x18986373 </plain></SENT>
</text></ref><ref id="B26"><text><SENT sid="536" pm="."><plain>Grubeck-LoebensteinBDella BellaSIorioAMMichelJPPawelecGSolanaRImmunosenescence and vaccine failure in the elderlyAging Clin Exp Res200921320120919571643 </plain></SENT>
</text></ref><ref id="B27"><text><SENT sid="537" pm="."><plain>Perrig-ChielloPHutchisonSHealth and well-being in old age: the pertinence of a gender mainstreaming approach in researchGerontology20105620821310.1159/00023581319707008 </plain></SENT>
</text></ref><ref id="B28"><text><SENT sid="538" pm="."><plain>MayRCGender, immunity and the regulation of longevityBioessays200729879580210.1002/bies.2061417621669 </plain></SENT>
</text></ref><ref id="B29"><text><SENT sid="539" pm="."><plain><ext-link ext-link-type="uri" xlink:href="http://www.istat.it">http://www.istat.it</ext-link> </plain></SENT>
</text></ref><ref id="B30"><text><SENT sid="540" pm="."><plain>CandoreGBalistreriCRColonna-RomanoGLioDListìFVastoSCarusoCGender-related immune-inflammatory factors, age-related diseases, and longevityRejuvenation Res20101329272910.1089/rej.2009.094220345280 </plain></SENT>
</text></ref><ref id="B31"><text><SENT sid="541" pm="."><plain>CandoreGBalistreriCRListìFGrimaldiMPVastoSColonna-RomanoGFranceschiCLioDCaselliGCarusoCImmunogenetics, gender, and longevityAnn N Y Acad Sci2006108951653710.1196/annals.1386.05117261795 </plain></SENT>
</text></ref><ref id="B32"><text><SENT sid="542" pm="."><plain>CapriMSalvioliSMontiDCarusoCCandoreGVastoSOlivieriFMarchegianiFSansoniPBaggioGMariDPassarinoGDe BenedictisGFranceschiCHuman longevity within an evolutionary perspective: The peculiar paradigm of a post-reproductive geneticsExp Gerontol200843536010.1016/j.exger.2007.06.00417692487 </plain></SENT>
</text></ref><ref id="B33"><text><SENT sid="543" pm="."><plain>LioDBalistreriCRColonna-RomanoGMottaMFranceschiCMalaguarneraMCandoreGCarusoCAssociation between the MHC class I gene HFE polymorphisms and longevity: a study in Sicilian populationGenes Immun20023202410.1038/sj.gene.636382311857056 </plain></SENT>
</text></ref><ref id="B34"><text><SENT sid="544" pm="."><plain>BeutlerEIron storage disease: facts, fiction and progressBlood Cells Mol Dis20073914014710.1016/j.bcmd.2007.03.00917540589 </plain></SENT>
</text></ref><ref id="B35"><text><SENT sid="545" pm="."><plain>PietrangeloAHereditary hemochromatosis: pathogenesis, diagnosis, and treatmentGastroenterology2010139393408408.e1-210.1053/j.gastro.2010.06.01320542038 </plain></SENT>
</text></ref><ref id="B36"><text><SENT sid="546" pm="."><plain>FranceschiCMottaLMottaMMalaguarneraMCapriMVastoSCandoreGCarusoCIMUSCE. </plain></SENT>
<SENT sid="547" pm="."><plain>The extreme longevity: the state of the art in ItalyExp Gerontol200843455210.1016/j.exger.2007.06.00617703905 </plain></SENT>
</text></ref><ref id="B37"><text><SENT sid="548" pm="."><plain>TroenBRThe biology of agingMt Sinai J Med20037032212516005 </plain></SENT>
</text></ref><ref id="B38"><text><SENT sid="549" pm="."><plain>OstanRBucciLCapriMSalvioliSScurtiMPiniEMontiDFranceschiCImmunosenescence and immunogenetics of human longevityNeuroimmunomodulation20081522424010.1159/00015646619047800 </plain></SENT>
</text></ref><ref id="B39"><text><SENT sid="550" pm="."><plain>CandoreGColonna-RomanoGBalistreriCRDi CarloDGrimaldiMPListìFNuzzoDVastoSLioDCarusoCBiology of longevity: role of the innate immune systemRejuvenation Res2006914314810.1089/rej.2006.9.14316608411 </plain></SENT>
</text></ref><ref id="B40"><text><SENT sid="551" pm="."><plain>WilliamsGCPleiotropy, natural selection, and the evolution of senescenceEvolution195739841111 </plain></SENT>
</text></ref><ref id="B41"><text><SENT sid="552" pm="."><plain>VastoSCandoreGBalistreriCRCarusoMColonna-RomanoGGrimaldiMPListiFNuzzoDLioDCarusoCInflammatory networks in ageing, age-related diseases and longevityMech Ageing Dev2007128839110.1016/j.mad.2006.11.01517118425 </plain></SENT>
</text></ref><ref id="B42"><text><SENT sid="553" pm="."><plain>BalistreriCRColonna-RomanoGLioDCandoreGCarusoCTLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseasesJ Clin Immunol20092940641510.1007/s10875-009-9297-519459036 </plain></SENT>
</text></ref><ref id="B43"><text><SENT sid="554" pm="."><plain>ArbourNCLorenzESchutteBCZabnerJKlineJNJonesMFreesKWattJLSchwartzDATLR4 mutations are associated with endotoxin hyporesponsiveness in humansNat Genet20002518719110.1038/7604810835634 </plain></SENT>
</text></ref><ref id="B44"><text><SENT sid="555" pm="."><plain>FerwerdaBMcCallMBAlonsoSGiamarellos-BourboulisEJMouktaroudiMùIzagirreNSyafruddinDKibikiGCristeaTHijmansAHamannLIsraelSElGhazaliGTroye-BlombergMKumpfOMaigaBDoloADoumboOHermsenCCStalenhoefAFvan CrevelRBrunnerHGOhDYSchumannRRde la RúaCSauerweinRKullbergBJvan der VenAJvan der MeerJWNeteaMGTLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humansProc Natl Acad Sci USA2007104166451665010.1073/pnas.070482810417925445 </plain></SENT>
</text></ref><ref id="B45"><text><SENT sid="556" pm="."><plain>FerwerdaBMcCallMBVerheijenKKullbergBJvan der VenAJVan der MeerJWNeteaMGFunctional consequences of toll-like receptor 4 polymorphismsMol Med20081434635218231573 </plain></SENT>
</text></ref><ref id="B46"><text><SENT sid="557" pm="."><plain>BalistreriCRCarusoCGrimaldiMPListìFVastoSOrlandoVCampagnaAMLioDCandoreGCCR5 receptor: biologic and genetic implications in age-related diseasesAnn NY Acad Sci2007110016217210.1196/annals.1395.01417460174 </plain></SENT>
</text></ref><ref id="B47"><text><SENT sid="558" pm="."><plain>ListìFCarusoMIncalcaterraEHoffmannECaimiGBalistreriCRVastoSScafidiVCarusoCCandoreGPro-inflammatory gene variants in myocardial infarction and longevity: implications for pharmacogenomicsCurr Pharm Des2008142678268510.2174/13816120878626411518991687 </plain></SENT>
</text></ref><ref id="B48"><text><SENT sid="559" pm="."><plain>BalistreriCRCandoreGCarusoMIncalcaterraEFranceschiCCarusoCRole of polymorphisms of CC-chemokine receptor-5 gene in acute myocardial infarction and biological implications for longevityHaematologica20089363763810.3324/haematol.1223918379014 </plain></SENT>
</text></ref><ref id="B49"><text><SENT sid="560" pm="."><plain>BalistreriCRCandoreGColonna-RomanoGLioDCarusoMHoffmannEFranceschiCCarusoCRole of Toll-like receptor 4 in acute myocardial infarction and longevityJAMA20042922339234010.1001/jama.292.19.233915547160 </plain></SENT>
</text></ref><ref id="B50"><text><SENT sid="561" pm="."><plain>PerlsTTerryDGenetics of exceptional longevityExp Gerontol20033872573010.1016/S0531-5565(03)00098-612855277 </plain></SENT>
</text></ref><ref id="B51"><text><SENT sid="562" pm="."><plain>CandoreGBalistreriCRGrimaldiMPListìFVastoSCarusoMCaimiGHoffmannEColonna-RomanoGLioDPaolissoGFranceschiCCarusoCOpposite role of pro-inflammatory alleles in acute myocardial infarction and longevity: results of studies performed in a Sicilian populationAnn NY Acad Sci 2006106727027510.1196/annals.1354.03516803997 </plain></SENT>
</text></ref><ref id="B52"><text><SENT sid="563" pm="."><plain>IncalcaterraECarusoMBalistreriCRCandoreGLo PrestiRHoffmannECaimiGRole of genetic polymorphisms in myocardial infarction at young ageClin Hemorheol Microcirc20104629129821187577 </plain></SENT>
</text></ref><ref id="B53"><text><SENT sid="564" pm="."><plain>BalistreriCRCarrubaGCalabròMCampisiIDi CarloDLioDColonna-RomanoGCandoreGCarusoCCCR5 proinflammatory allele in prostate cancer risk: a pilot study in patients and centenarians from SicilyAnn NY Acad Sci2009115528929210.1111/j.1749-6632.2008.03691.x19250219 </plain></SENT>
</text></ref><ref id="B54"><text><SENT sid="565" pm="."><plain>BalistreriCRCarusoCCarrubaGMiceliVCampisiIListìFLioDColonna-RomanoGCandoreGA pilot study on prostate cancer risk and pro-inflammatory genotypes: pathophysiology and therapeutic implicationsCurr Pharm Des20101671872410.2174/13816121079088387720388081 </plain></SENT>
</text></ref><ref id="B55"><text><SENT sid="566" pm="."><plain>BalistreriCRCandoreGLioDColonna-RomanoGDi LorenzoGMansuetoPRiniGMansuetoSCillariEFranceschiCCarusoCRole of TLR4 receptor polymorphisms in Boutonneuse feverInt J Immunopathol Pharmacol20051865566016388712 </plain></SENT>
</text></ref><ref id="B56"><text><SENT sid="567" pm="."><plain>BalistreriCRCarusoCListìFColonna-RomanoGLioDCandoreGLPS-mediated production of pro/anti-inflammatory cytokines and eicosanoids in whole blood samples: biological effects of +896A/G TLR4 polymorphism in a Sicilian population of healthy subjectsMech Ageing Dev2011132869210.1016/j.mad.2010.12.00521238472 </plain></SENT>
</text></ref><ref id="B57"><text><SENT sid="568" pm="."><plain>SanjabiSZenewiczLAKamanakaMFlavellRAAnti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunityCurr Opin Pharmacol2009944745310.1016/j.coph.2009.04.00819481975 </plain></SENT>
</text></ref><ref id="B58"><text><SENT sid="569" pm="."><plain>IannittiTPalmieriBInflammation and genetics: an insight in the centenarian modelHum Biol20118353155910.3378/027.083.040721846209 </plain></SENT>
</text></ref><ref id="B59"><text><SENT sid="570" pm="."><plain>CarusoCCandoreGColonna-RomanoGLioDFranceschiCInflammation and life-span. </plain></SENT>
<SENT sid="571" pm="."><plain>Science2005307208209 </plain></SENT>
</text></ref><ref id="B60"><text><SENT sid="572" pm="."><plain>LioDScolaLCrivelloAColonna-RomanoGCandoreGBonafèMCavalloneLFranceschiCCarusoCGender-specific association between -1082 IL-10 promoter polymorphism and longevityGenes Immun20023303310.1038/sj.gene.636382711857058 </plain></SENT>
</text></ref><ref id="B61"><text><SENT sid="573" pm="."><plain>LioDScolaLCrivelloAColonna-RomanoGCandoreGBonaféMCavalloneLMarchegianiFOlivieriFFranceschiCCarusoCInflammation, genetics, and longevity: further studies on the protective effects in men of IL-10-1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNPJ Med Genet20034029629910.1136/jmg.40.4.29612676903 </plain></SENT>
</text></ref><ref id="B62"><text><SENT sid="574" pm="."><plain>LioDCandoreGCrivelloAScolaLColonna-RomanoGCavalloneLHoffmannECarusoMLicastroFCaldareraCMBranziAFranceschiCCarusoCOpposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart diseaseJ Med Genet20044179079410.1136/jmg.2004.01988515466015 </plain></SENT>
</text></ref><ref id="B63"><text><SENT sid="575" pm="."><plain>LioDScolaLCrivelloABonafèMFranceschiCOlivieriFColonna-RomanoGCandoreGCarusoCAllele frequencies of +874 T- &gt; A single nucleotide polymorphism at the first intron of interferon-gamma gene in a group of Italian centenariansExp Gerontol20023731531910.1016/S0531-5565(01)00198-X11772518 </plain></SENT>
</text></ref><ref id="B64"><text><SENT sid="576" pm="."><plain>PalmeriMMisianoGMalaguarneraMForteGIVaccarinoLMilanoSScolaLCarusoCMottaMMaugeriDLioDCytokine serum profile in a group of sicilian nonagenariansJ Immunoassay Immunochem201233829010.1080/15321819.2011.60178122181823 </plain></SENT>
</text></ref><ref id="B65"><text><SENT sid="577" pm="."><plain>ParkLKFrisoSChoiSWNutritional influences on epigenetics and age-related diseaseProc Nutr Soc201271758310.1017/S002966511100330222051144 </plain></SENT>
</text></ref><ref id="B66"><text><SENT sid="578" pm="."><plain>PortelaAEstellerMEpigenetic modifications and human diseaseNat Biotechnol2010281057106810.1038/nbt.168520944598 </plain></SENT>
</text></ref><ref id="B67"><text><SENT sid="579" pm="."><plain>FukeCShimabukuroMPetronisASugimotoJOdaTMiuraKMiyazakiTOguraCOkazakiYJinnoYAge related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based studyAnn Hum Genet200569Pt 1134 </plain></SENT>
</text></ref><ref id="B68"><text><SENT sid="580" pm="."><plain>WuCMorrisJRGenes, genetics, and epigenetics: a correspondenceScience20012931103110510.1126/science.293.5532.110311498582 </plain></SENT>
</text></ref><ref id="B69"><text><SENT sid="581" pm="."><plain>AntequeraFBirdACpG islands. </plain></SENT>
<SENT sid="582" pm="."><plain>EXS199364169185 </plain></SENT>
</text></ref><ref id="B70"><text><SENT sid="583" pm="."><plain>DecottigniesAd'Adda di FagagnaFEpigenetic alterations associated with cellular senescence: a barrier against tumorigenesis or a red carpet for cancer?Semin Cancer Biol20112136036610.1016/j.semcancer.2011.09.00321946622 </plain></SENT>
</text></ref><ref id="B71"><text><SENT sid="584" pm="."><plain>LimUSongMADietary and lifestyle factors of DNA methylationMethods Mol Biol201286335937610.1007/978-1-61779-612-8_2322359306 </plain></SENT>
</text></ref><ref id="B72"><text><SENT sid="585" pm="."><plain>ChoiSWFrisoSEpigenetics: A New Bridge between Nutrition and HealthAdv Nutr2010181622043447 </plain></SENT>
</text></ref><ref id="B73"><text><SENT sid="586" pm="."><plain>VastoSScapagniniGRizzoCMonasteroRMarcheseACarusoCMediterranean diet and longevity in Sicily: a survey in Sicani Mountains PopulationRejuvenation Res in press  </plain></SENT>
</text></ref><ref id="B74"><text><SENT sid="587" pm="."><plain>MitićTEmanueliCDiabetes-induced epigenetic signature in vascular cellsEndocr Metab Immune Disord Drug Targets2012 </plain></SENT>
</text></ref><ref id="B75"><text><SENT sid="588" pm="."><plain>KurodaARauchTATodorovIKuHTAl-AbdullahIHKandeelFMullenYPfeiferGPFerreriKInsulin gene expression is regulated by DNA methylationPLoS One2009410 </plain></SENT>
</text></ref><ref id="B76"><text><SENT sid="589" pm="."><plain>ZhaoJGoldbergJBremnerJDVaccarinoVGlobal DNA methylation is associated with insulin resistance: a monozygotic twin studyDiabetes20126154254610.2337/db11-104822210312 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
